StockGlow

Oncoinvent ASA (0RU5.L)

Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer.

81.40-0.05%
Compare 0RU5.L with
StockGlow Score
96
Bullish
BearishBullish
1 year ago+6550.3%

The outlook

Oncoinvent ASA currently reads as bullish based on above its 50- & 200-day averages, 97% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range97% of the way from its 52-week low to high
Market cap
—
52-wk high
84.00
52-wk low
0.08
50-day avg
0.26
200-day avg
0.51
Trailing P/E
—

Similar stocks

0MTP.LIDEX Biometrics ASA$8.30-2.35%AREC.LArecor Therapeutics plc$61.00-3.94%TM1.LTechnology Minerals Plc$0.05+4.21%POLB.LPoolbeg Pharma PLC$6.70+4.69%0ROY.ILDavide Campari-Milano N.V.$10.12+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy